
A new study published in JAMA has suggested that Amgen, Sanofi and Regeneron would have to reduce their prices for …

GSK is charging up to four times more for its recently approved asthma drug Nucala than is justified by cost-effectiveness …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEO
Tridem begins phase Ib trial of Parkinson’s disease vaccine

